Key facts
| Price (PPV) | 18.90 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | acide tiaprofinique |
| Class | Antiinflammatory and antirheumatic products |
| ATC code | M01AE11 |
| Manufacturer | PHARMED |
| Presentation | Boite de 10 |
| Hospital price | 11.80 MAD |
| Data collected on | 9/8/2026 |
Indications
Elles sont limitées, chez l’adulte et l’enfant à partir de 15 kg (soit environ à partir de 4 ans), au : - traitement symptomatique au long cours : * des rhumatismes inflammatoires chroniques, notamment polyarthrite rhumatoïde, * de certaines arthroses douloureuses et invalidantes ; - traitement symptomatique de courte durée : * des poussées aiguës d’arthrose, de lombalgies, * des affections aiguës post-traumatiques bénignes de l’appareil locomoteur ; - dysménorrhée après recherche étiologique ; - traitement symptomatique de la douleur au cours des manifestations inflammatoires dans les domaines ORL et stomatologiques. Dans cette indication, les risques encourus, en particulier l’extension d’un processus
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
3 other products contain the same active substance as Atiaf 200 mg (Acide tiaprofinique), at the same strength and in the same dosage form. The prices below are per pack: compare pack sizes before comparing prices.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Molgam 200 mg | PHARMA5 | Boîte de 10 | 20.60 MAD | 2.06 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Atiaf 200 mg | PHARMED | Boite de 20 | 33.60 MAD | 1.68 / unit |
| Molgam 200 mg | PHARMA5 | Boîte de 20 | 37.40 MAD | 1.87 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Atiaf 200 mg
Atiaf 200 mg belongs to the antiinflammatory and antirheumatic products therapeutic class. In Morocco, this drug is marketed by PHARMED and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Atiaf 200 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Atiaf 200 mg
Answers to common questions from Moroccan patients about this drug.